US Stock MarketDetailed Quotes

NAVB Navidea Biopharmaceuticals

Watchlist
  • 0.000
  • 0.0000.00%
15min DelayClose Dec 20 16:00 ET
10.01KMarket Cap0.00P/E (TTM)

Navidea Biopharmaceuticals Key Stats

Navidea Biopharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Nov 10, 20212021/Q396.380K / 0.000--
Aug 11, 20212021/Q2261.050K / 600.000K--
May 11, 20212021/Q1123.740K / 600.000K--
Mar 24, 20212020/Q4219.250K / 300.000K--
Nov 12, 20202020/Q3268.390K / 150.000K--
DatePeriodRevenue/EstimateEarnings Call
Nov 10, 20212021/Q396.380K / 0.000--
Aug 11, 20212021/Q2261.050K / 600.000K--
May 11, 20212021/Q1123.740K / 600.000K--
Mar 24, 20212020/Q4219.250K / 300.000K--
Nov 12, 20202020/Q3268.390K / 150.000K--

Unlock Free Earnings Estimates

Navidea Biopharmaceuticals Earnings Reports

Read more

Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.